Evaluation of HPRT Gene mutation and Comet Assay in Some Breast Cancer Patients Undergoing Radiotherapy
Keywords:Radiotherapy, Breast Cancer, HPRT gene, comet assay
Introduction: Radiotherapy is a toxic cellular treatment that destroys rapidly dividing cells such as cancer
cells. The strategy for HPRT mutation examination in human’s cells was commonly used to establish in vivo
history along with mutation rates in children and adults inhabitants subjected to experienced and unfamiliar
external mutagens. As just a practical approach to human biosurveillance studies, the comet assay has
been introduced over the past years as biomarker to identify ionizing radiation Consequences with Patients
undergoing radiotherapy in breast cancer.
Materials and Method: This study was carried out on thirty Iraqi women patients with BC patients
undergoing radiotherapy about 20-30 Gy locally gamma cells at Al-Amel National Hospital for cancer
Management in Baghdad during time 2-13 years, non-smokers and non- alcoholic, aged (35-55 year),
with stage (grade) I-III, as well as thirty apparently healthy individuals females collected randomly from
population living Baghdad, Old age (35-55) Which are non-alcoholic non-smokers as group of control.
Around the ongoing research comet-test and hprt mutation test could be applied to study damages in DNA
for genetic two endpoints For patients with cancer throughout radiation therapy.
Results: The present study showed significant increase (p<0.05) in the HPRT gene mutation assay for the
in breast cancer patients undergoing radiotherapy as compared with the control group. Also there were
found that the values of comet tail moment and tail length was increased significantly (p<0.05) in the human
lymphocyte in these for breast cancer patients undergoing radiotherapy as compared with the control group.
Conclusions: Present results revealed that there is a probability of utilizing human lymphocytes changes as
useful biodosimetric markers for the detection of human exposure to ionizing radiation, the data gathered
also demonstrated the utility of the HPRT gene mutation and (Alkaline) comet test as just a precise alternative
biological marker for routine preventative care of cancer patients receiving radiation therapy.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Re use and mixing of content policy- We follow Creative Commons Licence Policy. We follow CC BY. Please refer below for all details
This license lets others distribute, remix, adapt, and build upon our work, even commercially, as long as they credit us for the original creation.
- The journal allows readers to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose.
- The journal allows the author(s) to hold the copyright without restrictions.
- The journal allows the author(s) to retain publishing rights without restrictions